ATE192926T1 - Flavopereirine enthaltende zusammensetzung und ihre anwendung in der behandlung gegen hiv-viren - Google Patents

Flavopereirine enthaltende zusammensetzung und ihre anwendung in der behandlung gegen hiv-viren

Info

Publication number
ATE192926T1
ATE192926T1 AT93916037T AT93916037T ATE192926T1 AT E192926 T1 ATE192926 T1 AT E192926T1 AT 93916037 T AT93916037 T AT 93916037T AT 93916037 T AT93916037 T AT 93916037T AT E192926 T1 ATE192926 T1 AT E192926T1
Authority
AT
Austria
Prior art keywords
flavopereirine
pct
date feb
sec
active agent
Prior art date
Application number
AT93916037T
Other languages
English (en)
Inventor
Mirko Beljanski
Original Assignee
Molecular International Resear
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular International Resear filed Critical Molecular International Resear
Application granted granted Critical
Publication of ATE192926T1 publication Critical patent/ATE192926T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93916037T 1992-07-28 1993-07-26 Flavopereirine enthaltende zusammensetzung und ihre anwendung in der behandlung gegen hiv-viren ATE192926T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9209284A FR2694693B1 (fr) 1992-07-28 1992-07-28 Composition pharmaceutique à base de flavopéréirine et son utilisation dans un traitement contre le virus VIH.
PCT/FR1993/000761 WO1994002146A1 (fr) 1992-07-28 1993-07-26 Composition pharmaceutique a base de flavopereirine et son utilisation dans un traitement contre le virus vih

Publications (1)

Publication Number Publication Date
ATE192926T1 true ATE192926T1 (de) 2000-06-15

Family

ID=9432328

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93916037T ATE192926T1 (de) 1992-07-28 1993-07-26 Flavopereirine enthaltende zusammensetzung und ihre anwendung in der behandlung gegen hiv-viren

Country Status (11)

Country Link
US (1) US5519028A (de)
EP (1) EP0605700B1 (de)
JP (1) JPH07502754A (de)
AT (1) ATE192926T1 (de)
CA (1) CA2120001C (de)
DE (1) DE69328667T2 (de)
ES (1) ES2148234T3 (de)
FR (1) FR2694693B1 (de)
IL (1) IL106491A (de)
PT (1) PT605700E (de)
WO (1) WO1994002146A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050159400A1 (en) * 2003-07-22 2005-07-21 Hamann Mark T. Manzamines in the treatment of infectious disease
CA2526586C (en) 2003-09-09 2010-03-16 Biogen International Gmbh The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
CN101027070B (zh) * 2004-05-19 2012-08-08 自然来源国际公司 治疗和预防前列腺癌中的黄佩瑞任和鸡骨常山碱组合
EP1758904B1 (de) * 2004-06-11 2009-06-03 Dabur Pharma Ltd. Flavopereirinderivate zur krebstherapie
EP1799196B1 (de) 2004-10-08 2016-06-22 Forward Pharma A/S Pharmazeutische zusammensetzung mit kontrollierter freisetzung mit einem fumarsäureester
EP2139467B1 (de) * 2007-02-08 2016-09-21 Biogen MA Inc. Nervenschutz bei entmarkungserkrankungen
EP3773582B1 (de) 2018-03-31 2023-10-25 Molecular International Research, Inc. Selektives antikrebsmittel zur vorbeugung und behandlung
EP4028020A4 (de) 2019-09-11 2023-09-27 The Scripps Research Institute Antivirale prodrugs und deren formulierungen
US20230060934A1 (en) * 2021-08-25 2023-03-02 Michael Wayne Dockery Botanical antiviral nutritional supplement

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450607A2 (fr) * 1978-03-13 1980-10-03 Beljanski Mirko Composition pharmaceutique contenant comme principe actif la flavopereine
DE3172570D1 (en) * 1981-03-11 1985-11-14 Mirko Beljanski Serpentine, alstonine and sempervirine drugs for the specific inhibition of tumurous and cancerous cells
FR2633182B1 (fr) * 1988-06-23 1993-07-23 Beljanski Mirko Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention
FR2639830B1 (fr) * 1988-12-02 1991-03-22 Beljanski Mirko Composition antivirale et ses applications
US5011853A (en) * 1989-08-25 1991-04-30 Washington University Compounds for treatment of cholinergic neurotoxins
CH679982A5 (en) * 1990-01-19 1992-05-29 Debiopharm Sa Anti-retroviral compsn. contg. 2-methyl-9-hydroxy-ellipticine acetate - esp. for treatment or prevention of AIDS with greater activity than AZT

Also Published As

Publication number Publication date
FR2694693A1 (fr) 1994-02-18
JPH07502754A (ja) 1995-03-23
WO1994002146A1 (fr) 1994-02-03
EP0605700B1 (de) 2000-05-17
IL106491A (en) 1998-12-06
IL106491A0 (en) 1993-11-15
FR2694693B1 (fr) 1994-10-28
CA2120001C (en) 2005-02-08
DE69328667D1 (de) 2000-06-21
PT605700E (pt) 2000-12-29
US5519028A (en) 1996-05-21
CA2120001A1 (en) 1994-02-03
DE69328667T2 (de) 2001-02-08
EP0605700A1 (de) 1994-07-13
ES2148234T3 (es) 2000-10-16

Similar Documents

Publication Publication Date Title
JP3133345B2 (ja) Ｈｉｖに対して活性な連結環状ポリアミン
UA40589C2 (uk) Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація
EP1611885A8 (de) Verwendung eines induzierenden Wirkstoffes zur Behandlung von Blut, Viralen und zellulären Störungen
EA200601281A1 (ru) Азабензофуранзамещенные тиомочевины; ингибиторы репликации вирусов
JP2002528502A5 (de)
ATE192926T1 (de) Flavopereirine enthaltende zusammensetzung und ihre anwendung in der behandlung gegen hiv-viren
WO1991002529A2 (en) Product and method for killing abnormal vertebrate cells
WO2006044968A3 (en) Combination therapy for treating viral infections
KR860003018A (ko) 1-β-D-리보푸라노실-1,2,4-트리아졸-3-카르복사미드를 이용한 인체의 비루스성 질환의 의학적 치료방법
KR910018393A (ko) 항바이러스제로서의 비대칭 2-(포스포노메톡시)프로필 구아닌
TR200103144T2 (tr) Yeni bileşikler
KR100227125B1 (ko) 미포자충감염을치료하기위한벤즈이미다졸구충제의용도
DK1143976T3 (da) Beta-D-2', 3'-didehydro-2', 3'-dideoxy-5-fluorcytidin til anvendelse i behandlingen af HIV-infektioner
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
KR950702413A (ko) 암치료에 2-(4-(4-클로로페닐)시클로헥실)-3-히드록시-1, 4-나프토퀴논을 사용하는 방법(use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer)
EP1155694A4 (de) Mittel gegen hiv-infektionen und verfahren zur behandlung von hiv-infektionen
TR200200111T2 (tr) Neoplazmalar için terapötik ve profilaktik maddeler
EP1731155A3 (de) Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine für die verwendung in der behandlung von hiv infektionen
DK200000687A (da) Middel til forsøgelse af afgivelsen af cerebral acetylcholin
UA144734U (uk) Спосіб лікування вірусних інфекційних захворювань
RU2000108989A (ru) Способ профилактики и лечения респираторных болезней телят
JPH03251526A (ja) 糖尿病依存型自己免疫疾患治療、予防用薬剤
NO931338L (no) Forbindelser og fremgangsmaater for inhibering av hiv og beslektede virus
JPH02275819A (ja) エイズ原因ウィルスに対する抗ウィルス剤
James PMPA--first human results

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee